期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Cholangiocarcinoma and liver transplantation:What we know so far? 被引量:2
1
作者 Ali Reza Safarpour Hassan Askari +10 位作者 Farshid Ejtehadi Asaad Azarnezhad Ehsan Raeis-Abdollahi Amir Tajbakhsh Mohammad Foad Abazari Firoozeh Tarkesh Alireza Shamsaeefar Ramin Niknam Gholam Reza Sivandzadeh Kamran Bagheri Lankarani Fardad Ejtehadi 《World Journal of Gastrointestinal Pathophysiology》 2021年第5期84-105,共22页
Cholangiocarcinoma(CCA)is a type of cancer with increasing prevalence around the world that originates from cholangiocytes,the epithelial cells of the bile duct.The tumor begins insidiously and is distinguished by hig... Cholangiocarcinoma(CCA)is a type of cancer with increasing prevalence around the world that originates from cholangiocytes,the epithelial cells of the bile duct.The tumor begins insidiously and is distinguished by high grade neoplasm,poor outcome,and high risk for recurrence.Liver transplantation has become broadly accepted as a treatment option for CCA.Liver transplantation is expected to play a crucial role as palliative and curative therapy for unresectable hilar CCA and intrahepatic CCA.The purpose of this study was to determine which cases with CCA should be subjected to liver transplantation instead of resection,although reported post-transplant recurrence rate averages approximately 20%.This review also aims to highlight the molecular current frontiers of CCA and directions of liver transplantation for CCA. 展开更多
关键词 CHOLANGIOCARCINOMA Liver transplantation Primary sclerosing cholangitis Neoadjuvant chemoradiotherapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部